OA10747A - Pyrrolidinyl methyl indole salt - Google Patents

Pyrrolidinyl methyl indole salt Download PDF

Info

Publication number
OA10747A
OA10747A OA70132A OA70132A OA10747A OA 10747 A OA10747 A OA 10747A OA 70132 A OA70132 A OA 70132A OA 70132 A OA70132 A OA 70132A OA 10747 A OA10747 A OA 10747A
Authority
OA
OAPI
Prior art keywords
sait
fumarate
compound
indole
methylpyrrolidin
Prior art date
Application number
OA70132A
Other languages
English (en)
Inventor
Martin James Wythes
Original Assignee
Pfizer Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Res & Dev filed Critical Pfizer Res & Dev
Publication of OA10747A publication Critical patent/OA10747A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
OA70132A 1995-05-20 1997-11-20 Pyrrolidinyl methyl indole salt OA10747A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9510223.2A GB9510223D0 (en) 1995-05-20 1995-05-20 Therapeutic agent

Publications (1)

Publication Number Publication Date
OA10747A true OA10747A (en) 2002-12-11

Family

ID=10774766

Family Applications (1)

Application Number Title Priority Date Filing Date
OA70132A OA10747A (en) 1995-05-20 1997-11-20 Pyrrolidinyl methyl indole salt

Country Status (42)

Country Link
US (1) US5994387A (is)
EP (1) EP0827503B1 (is)
JP (1) JP3233940B2 (is)
KR (1) KR100295255B1 (is)
CN (1) CN1063175C (is)
AP (1) AP738A (is)
AR (1) AR003949A1 (is)
AT (1) ATE194986T1 (is)
AU (1) AU701154B2 (is)
BG (1) BG63046B1 (is)
BR (1) BR9610858A (is)
CA (1) CA2219631C (is)
CO (1) CO5040221A1 (is)
CZ (1) CZ287939B6 (is)
DE (1) DE69609504T2 (is)
DK (1) DK0827503T3 (is)
DZ (1) DZ2034A1 (is)
ES (1) ES2148753T3 (is)
GB (1) GB9510223D0 (is)
GR (1) GR3034290T3 (is)
HK (1) HK1017884A1 (is)
HR (1) HRP960223B1 (is)
HU (1) HU217657B (is)
IL (1) IL118239A (is)
IS (1) IS1908B (is)
LV (1) LV11992B (is)
MA (1) MA23876A1 (is)
MX (1) MX9708966A (is)
MY (1) MY132066A (is)
NO (1) NO312068B1 (is)
NZ (1) NZ306448A (is)
OA (1) OA10747A (is)
PL (1) PL183142B1 (is)
PT (1) PT827503E (is)
RU (1) RU2161618C2 (is)
SK (1) SK281782B6 (is)
TN (1) TNSN96074A1 (is)
TR (1) TR199701397T1 (is)
UA (1) UA44320C2 (is)
WO (1) WO1996036632A1 (is)
YU (1) YU29496A (is)
ZA (1) ZA963938B (is)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9825988D0 (en) * 1998-11-27 1999-01-20 Pfizer Ltd Indole derivatives
US20100266638A1 (en) * 2004-02-26 2010-10-21 Allergan, Inc. Headache treatment method
EP2875020B1 (en) * 2012-07-19 2017-09-06 Boehringer Ingelheim International GmbH Process for the preparation of a fumaric acid salt of 9-[4-(3-chloro-2-fluoro-phenylamino)-7-methoxy- chinazolin-6-yloxy]-1,4-diaza-spiro[5.5]undecan-5-one

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3906406C1 (is) * 1989-03-01 1990-10-25 Goedecke Ag, 1000 Berlin, De
HUT64326A (en) * 1990-10-15 1993-12-28 Pfizer Process for production indole derivatives and pharmaceutical preparations containing these compounds
US5545644A (en) * 1990-10-15 1996-08-13 Pfizer Inc. Indole derivatives
AP486A (en) * 1993-04-27 1996-04-16 Pfizer Indole derivatives.

Also Published As

Publication number Publication date
CN1185152A (zh) 1998-06-17
HUP9801761A3 (en) 1999-06-28
HRP960223A2 (en) 1997-10-31
DE69609504T2 (de) 2000-12-14
KR19990014934A (ko) 1999-02-25
NO975210L (no) 1997-11-13
KR100295255B1 (ko) 2001-08-07
ZA963938B (en) 1997-11-17
BG102053A (en) 1998-06-30
DZ2034A1 (fr) 2002-07-21
EP0827503A1 (en) 1998-03-11
MX9708966A (es) 1998-03-31
LV11992B (en) 1998-06-20
IS1908B (is) 2003-12-31
LV11992A (lv) 1998-03-20
JP3233940B2 (ja) 2001-12-04
BR9610858A (pt) 1999-07-13
AU5500596A (en) 1996-11-29
SK154197A3 (en) 1999-01-11
TNSN96074A1 (fr) 2005-03-15
AR003949A1 (es) 1998-09-30
CN1063175C (zh) 2001-03-14
TR199701397T1 (xx) 1998-03-21
PL183142B1 (pl) 2002-05-31
PL323143A1 (en) 1998-03-16
PT827503E (pt) 2000-11-30
HU217657B (hu) 2000-03-28
GB9510223D0 (en) 1995-07-19
DK0827503T3 (da) 2000-11-20
US5994387A (en) 1999-11-30
NO312068B1 (no) 2002-03-11
CZ364897A3 (cs) 1998-11-11
GR3034290T3 (en) 2000-12-29
MA23876A1 (fr) 1996-12-31
CA2219631C (en) 2001-01-23
CZ287939B6 (cs) 2001-03-14
EP0827503B1 (en) 2000-07-26
RU2161618C2 (ru) 2001-01-10
AU701154B2 (en) 1999-01-21
IL118239A0 (en) 1996-09-12
IL118239A (en) 2000-10-31
MY132066A (en) 2007-09-28
BG63046B1 (bg) 2001-02-28
HUP9801761A2 (hu) 1999-05-28
HRP960223B1 (en) 2000-12-31
HK1017884A1 (en) 1999-12-03
WO1996036632A1 (en) 1996-11-21
ES2148753T3 (es) 2000-10-16
DE69609504D1 (de) 2000-08-31
ATE194986T1 (de) 2000-08-15
UA44320C2 (uk) 2002-02-15
AP738A (en) 1999-03-23
CA2219631A1 (en) 1996-11-21
YU29496A (sh) 1998-12-23
NZ306448A (en) 1998-10-28
IS4605A (is) 1997-10-30
NO975210D0 (no) 1997-11-13
SK281782B6 (sk) 2001-07-10
CO5040221A1 (es) 2001-05-29
AP9600801A0 (en) 1996-04-30
JPH10506639A (ja) 1998-06-30

Similar Documents

Publication Publication Date Title
UA44718C2 (uk) КРИСТАЛІЧНА ФОРМА МЕТАНСУЛЬФОНАТНОЇ СОЛІ 7-([1<font face="Symbol">a</font>,5<font face="Symbol">a</font>,6<font face="Symbol">a</font>]-6-АМІНО-3-АЗАБІЦИКЛО[3.1.0]ГЕКС-3-ІЛ)-6-ФТОР-1-(2,4-ДИФТОРФЕНІЛ)-1,4-ДИГІДРО-4-ОКСО-1,8-НАФТИРИДИН-3-КАРБОНОВОЇ КИСЛОТИ, СПОСІБ ЇЇ ОДЕРЖАННЯ, ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ, ЩО МАЄ ПРОТИБАКТЕРІАЛЬНУ АКТИВНІСТЬ, ТА СПОСІБ ЛІКУВАННЯ БАКТЕРІАЛЬНОЇ ІНФЕКЦІЇ
CA3160897A1 (en) Crystalline form of a 7h-benzo[7]annulene-2-carboxylic acid derivative
CA2410867C (en) Stable gabapentin containing more than 2o ppm of chlorine ion
OA10747A (en) Pyrrolidinyl methyl indole salt
EP2874628A2 (en) Salts and hydrates of antipsychotics
JPS6045878B2 (ja) Ｎ，ｎ’−二置換環状ジアミン及び精神病治療用薬剤
JP2021510149A (ja) アカラブルチニブの新規結晶形及びその製造方法並びに用途
EP3328842B1 (en) Process for the preparation of isocarboxazid
EP1549617A1 (en) Organic acid salt of amlodipine
US20240294479A1 (en) Polymorphs of 2-(3,5-dichlorophenyl)-l,3-benzoxazole-6-carboxylic acid
US4404205A (en) 2-Oxo-2,6,7,8,9,10 hexahydro-pyrimido[1,2-a]azepines and antianginal method of use thereof and of 4-oxo-4,6,7,8,9,10-hexahydropyrimido[1,2-a]azepines
EP3372592A1 (en) Solid forms of lesinurad amine salts
FR2539739A1 (fr) Nouveaux derives de la naphtyl pyridazine actifs sur le systeme nerveux central, procede de preparation de ces derives et medicaments en contenant